Maxim Group reiterated their buy rating on shares of Milestone Scientific Inc. (NASDAQ:MLSS) in a report published on Friday morning. Maxim Group currently has a $4.00 price target on the stock.

Shares of Milestone Scientific (NASDAQ:MLSS) traded up 8.00% on Friday, hitting $1.35. The stock had a trading volume of 36,198 shares. Milestone Scientific has a 52 week low of $1.08 and a 52 week high of $2.15. The firm has a 50 day moving average price of $1.27 and a 200-day moving average price of $1.35. The company’s market cap is $44.54 million.

ILLEGAL ACTIVITY NOTICE: This piece was reported by Watch List News and is the sole property of of Watch List News. If you are accessing this piece on another publication, it was copied illegally and republished in violation of U.S. and international copyright & trademark law. The legal version of this piece can be viewed at https://www.watchlistnews.com/milestone-scientifics-mlss-buy-rating-reaffirmed-at-maxim-group/1616137.html.

Milestone Scientific Company Profile

Milestone Scientific Inc (Milestone) is engaged in providing computer-controlled injection technologies and solutions for the medical and dental markets. The Company uses its CompuFlo technology for the delivery of medicaments. The CompuFlo pressure or force Computer-Controlled Local Anesthetic Delivery (C-CLAD) technology is a medical technology for the delivery of drugs, anesthetics and other medicaments into various tissue types.

Receive News & Ratings for Milestone Scientific Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Milestone Scientific Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.